Summary
Updated Aug 31, 2026
Phillip Md Et Al Frost is Director, 10% Owner of Cocrystal Pharma, Inc. (COCP). 31 SEC Form 4 filings on record going back to 2024, most recently on 6 August 2026. Most recent open-market trade: bought $10K of COCP on 6 August 2026. Lifetime open-market purchases: $7.91M. Historical track record: 4/5 stars across 50 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction Phillip Md Et Al Frost has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 50 |
| Purchases with forward-return data | 50 |
| 30-day win rate | 64% |
| 90-day win rate | 28% |
| Avg 5-day return | +2.17% |
| Avg 30-day return | +1.23% |
| Avg 90-day return | -1.48% |
| Best 30-day return | +13.60% |
Trading Pattern
InsiderAlpha's records for Phillip Md Et Al Frost go back to 2024: 31 primary Form 4 filings, an average of 10.3 per year. The typical open-market purchase is $152K (52 buys totaling $7.91M). The largest single buy on record is $1.50M of FLNT in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Phillip Md Et Al Frost's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Weiss Asset Management LP - $233.35M of AVDL open-market activity in the last 12 months
- James Edgemond - $201.52M of UTHR open-market activity in the last 12 months
- Scilex Holding Co - $200.00M of SMNR open-market activity in the last 12 months
- Michael Benkowitz - $199.02M of UTHR open-market activity in the last 12 months
- John Oyler - $198.67M of ONC open-market activity in the last 12 months
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Phillip Md Et Al Frost?
Phillip Md Et Al Frost is a corporate insider, tracked as Director, 10% Owner of Cocrystal Pharma, Inc. (COCP). InsiderAlpha holds 31 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Phillip Md Et Al Frost submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Phillip Md Et Al Frost been buying or selling stock?
Recorded transactions: 52 open-market purchases ($7.91M) and 0 open-market sales across all tracked filings.
How accurate is Phillip Md Et Al Frost's historical track record?
Across 50 tracked purchases, Phillip Md Et Al Frost averaged +1.2% avg 30-day return with a 64% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Phillip Md Et Al Frost's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Phillip Md Et Al Frost and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial